These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 17259348

  • 21. PC-1/PrLZ contributes to malignant progression in prostate cancer.
    Zhang H, Wang J, Pang B, Liang RX, Li S, Huang PT, Wang R, Chung LW, Zhau HE, Huang C, Zhou JG.
    Cancer Res; 2007 Sep 15; 67(18):8906-13. PubMed ID: 17875733
    [Abstract] [Full Text] [Related]

  • 22. JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells.
    Mehraein-Ghomi F, Lee E, Church DR, Thompson TA, Basu HS, Wilding G.
    Prostate; 2008 Jun 15; 68(9):924-34. PubMed ID: 18386285
    [Abstract] [Full Text] [Related]

  • 23. Molecular regulation of androgen action in prostate cancer.
    Dehm SM, Tindall DJ.
    J Cell Biochem; 2006 Oct 01; 99(2):333-44. PubMed ID: 16518832
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
    Tsui KH, Feng TH, Chung LC, Chao CH, Chang PL, Juang HH.
    Anticancer Res; 2008 Oct 01; 28(4A):1969-76. PubMed ID: 18649734
    [Abstract] [Full Text] [Related]

  • 26. Hypoxia increases androgen receptor activity in prostate cancer cells.
    Park SY, Kim YJ, Gao AC, Mohler JL, Onate SA, Hidalgo AA, Ip C, Park EM, Yoon SY, Park YM.
    Cancer Res; 2006 May 15; 66(10):5121-9. PubMed ID: 16707435
    [Abstract] [Full Text] [Related]

  • 27. Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP.
    Koochekpour S, Lee TJ, Wang R, Sun Y, Delorme N, Hiraiwa M, Grabowski GA, Culig Z, Minokadeh A.
    J Cell Biochem; 2007 Jun 01; 101(3):631-41. PubMed ID: 17171640
    [Abstract] [Full Text] [Related]

  • 28. IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.
    Péant B, Gilbert S, Le Page C, Poisson A, L'Ecuyer E, Boudhraa Z, Bienz MN, Delvoye N, Saad F, Mes-Masson AM.
    Oncotarget; 2017 Feb 28; 8(9):14487-14501. PubMed ID: 27577074
    [Abstract] [Full Text] [Related]

  • 29. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.
    Gavrielides MV, Gonzalez-Guerrico AM, Riobo NA, Kazanietz MG.
    Cancer Res; 2006 Dec 15; 66(24):11792-801. PubMed ID: 17178875
    [Abstract] [Full Text] [Related]

  • 30. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
    Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL.
    Cancer Res; 2007 Jul 15; 67(14):6854-62. PubMed ID: 17638896
    [Abstract] [Full Text] [Related]

  • 31. Conversion of prostate cancer from hormone independency to dependency due to AMACR inhibition: involvement of increased AR expression and decreased IGF1 expression.
    Takahara K, Azuma H, Sakamoto T, Kiyama S, Inamoto T, Ibuki N, Nishida T, Nomi H, Ubai T, Segawa N, Katsuoka Y.
    Anticancer Res; 2009 Jul 15; 29(7):2497-505. PubMed ID: 19596919
    [Abstract] [Full Text] [Related]

  • 32. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
    Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NL.
    Cancer Res; 2006 Nov 01; 66(21):10594-602. PubMed ID: 17079484
    [Abstract] [Full Text] [Related]

  • 33. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
    Gnanapragasam VJ, Darby S, Khan MM, Lock WG, Robson CN, Leung HY.
    J Pathol; 2005 Jun 01; 206(2):205-13. PubMed ID: 15818594
    [Abstract] [Full Text] [Related]

  • 34. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 01; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 35. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 36. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
    Schatten H, Ripple M, Balczon R, Weindruch R, Chakrabarti A, Taylor M, Hueser CN.
    J Cell Biochem; 2000 Jan 15; 76(3):463-77. PubMed ID: 10649443
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
    You Z, Shi XB, DuRaine G, Haudenschild D, Tepper CG, Lo SH, Gandour-Edwards R, de Vere White RW, Reddi AH.
    Cancer Res; 2006 Jan 01; 66(1):175-83. PubMed ID: 16397230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.